Published in PLoS One on October 17, 2011
The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe (2015) 2.58
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes. Diabetes (2015) 2.21
A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia (2015) 2.02
Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol (2013) 1.97
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med (2013) 1.71
Assessing the human gut microbiota in metabolic diseases. Diabetes (2013) 1.64
Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS One (2015) 1.63
A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development. Elife (2016) 1.46
Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. J Histochem Cytochem (2014) 1.40
Th17 cells in immunity and autoimmunity. Clin Dev Immunol (2013) 1.40
Frequent replenishment sustains the beneficial microbiome of Drosophila melanogaster. MBio (2013) 1.26
Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.25
The human microbiome: from symbiosis to pathogenesis. Annu Rev Med (2013) 1.25
Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J (2013) 1.21
Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med (2015) 1.18
Functional assignment of metagenomic data: challenges and applications. Brief Bioinform (2012) 1.13
Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels. PLoS One (2013) 1.12
Fecal microbiota imbalance in Mexican children with type 1 diabetes. Sci Rep (2014) 1.10
Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. AIDS (2013) 1.10
HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One (2014) 1.07
The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem (2013) 1.07
Gut microbiota, probiotics and diabetes. Nutr J (2014) 1.06
Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia (2012) 1.04
VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation. PLoS One (2012) 1.02
The intestinal microbiome in type 1 diabetes. Clin Exp Immunol (2014) 1.02
Exploring gut microbes in human health and disease: Pushing the envelope. Genes Dis (2014) 0.99
Impacts of gut bacteria on human health and diseases. Int J Mol Sci (2015) 0.97
Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol (2016) 0.97
Characterisation of the faecal bacterial community in adult and elderly horses fed a high fibre, high oil or high starch diet using 454 pyrosequencing. PLoS One (2014) 0.96
Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat Rev Endocrinol (2013) 0.96
Genome resolved analysis of a premature infant gut microbial community reveals a Varibaculum cambriense genome and a shift towards fermentation-based metabolism during the third week of life. Microbiome (2013) 0.95
Identification of a core bacterial community within the large intestine of the horse. PLoS One (2013) 0.94
Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care (2014) 0.94
The role of the intestinal microbiota in type 1 diabetes mellitus. Nat Rev Endocrinol (2016) 0.93
Functional profiling of the gut microbiome in disease-associated inflammation. Genome Med (2013) 0.93
Microbiota and autoimmunity: exploring new avenues. Cell Host Microbe (2015) 0.93
Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol (2014) 0.92
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol (2014) 0.91
Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev (2015) 0.91
Metabolomics--a novel window into inflammatory disease. Swiss Med Wkly (2013) 0.91
Diabetes-related alterations in the enteric nervous system and its microenvironment. World J Diabetes (2012) 0.89
Gut microbiota and type 1 diabetes. Rev Diabet Stud (2012) 0.89
Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis. Invest Ophthalmol Vis Sci (2016) 0.89
The intestinal microbiota: its role in health and disease. Eur J Pediatr (2015) 0.88
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice. Proc Natl Acad Sci U S A (2016) 0.87
Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice. J Exp Med (2016) 0.87
The gut microbiota and Type 1 Diabetes. Clin Immunol (2015) 0.87
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol (2014) 0.86
Association of obesity with serum leptin, adiponectin, and serotonin and gut microflora in beagle dogs. J Vet Intern Med (2014) 0.86
The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord (2015) 0.86
Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice. Gut Microbes (2015) 0.86
The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury. BMC Gastroenterol (2013) 0.85
The role of Gut Microbiota in the development of obesity and Diabetes. Lipids Health Dis (2016) 0.84
Blood-based signatures in type 1 diabetes. Diabetologia (2015) 0.84
The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood. Clin Med Insights Pediatr (2016) 0.84
Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis (2015) 0.84
Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes. Am J Clin Exp Immunol (2013) 0.84
Differences in microbial signatures between rectal mucosal biopsies and rectal swabs. Gut Microbes (2012) 0.84
Regulatory properties of the intestinal microbiome effecting the development and treatment of diabetes. Curr Opin Endocrinol Diabetes Obes (2012) 0.83
American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome. Diabetes (2015) 0.82
Maternal Antibiotic Treatment Protects Offspring from Diabetes Development in Nonobese Diabetic Mice by Generation of Tolerogenic APCs. J Immunol (2015) 0.82
The microbiology of human hygiene and its impact on type 1 diabetes. Islets (2012) 0.81
Pancreatic regulation of glucose homeostasis. Exp Mol Med (2016) 0.81
Generation of primary human intestinal T cell transcriptomes reveals differential expression at genetic risk loci for immune-mediated disease. Gut (2014) 0.81
Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatr Diabetes (2015) 0.81
Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol (2017) 0.81
Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr (2013) 0.80
Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution. Nutrients (2015) 0.80
Research on neonatal microbiomes: what neonatologists need to know. Neonatology (2013) 0.80
The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. Sci Rep (2015) 0.79
Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. J Diabetes Res (2015) 0.79
The gut microbiome in autoimmunity: Sex matters. Clin Immunol (2015) 0.79
Host-Microbiota Interactions in the Pathogenesis of Antibiotic-Associated Diseases. Cell Rep (2016) 0.79
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol (2017) 0.79
Antibodies to Lactobacilli and Bifidobacteria in young children with different propensity to develop islet autoimmunity. J Immunol Res (2014) 0.78
Rapid comparison and correlation analysis among massive number of microbial community samples based on MDV data model. Sci Rep (2014) 0.78
Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome (2015) 0.78
Administration of defined microbiota is protective in a murine Salmonella infection model. Sci Rep (2015) 0.78
Intestinal dysbiosis and probiotic applications in autoimmune diseases. Immunology (2017) 0.78
Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. Proc Natl Acad Sci U S A (2017) 0.77
PBHMDA: Path-Based Human Microbe-Disease Association Prediction. Front Microbiol (2017) 0.77
Type 1 diabetes and gut microbiota: Friend or foe? Pharmacol Res (2015) 0.77
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies. J Diabetes Res (2015) 0.77
Metabolomics in the studies of islet autoimmunity and type 1 diabetes. Rev Diabet Stud (2012) 0.77
Captivity humanizes the primate microbiome. Proc Natl Acad Sci U S A (2016) 0.77
The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS One (2014) 0.77
Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment. PLoS One (2017) 0.77
Role of the gastrointestinal ecosystem in the development of type 1 diabetes. Pediatr Diabetes (2015) 0.76
Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome (2016) 0.76
Targeting gut microbiota: a potential promising therapy for diabetic kidney disease. Am J Transl Res (2016) 0.75
Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle. Front Genet (2017) 0.75
Autoimmune Hepatitis in Hawai'i. Hawaii J Med Public Health (2015) 0.75
Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults. Appl Environ Microbiol (2016) 0.75
Transcriptomic changes in an animal-bacterial symbiosis under modeled microgravity conditions. Sci Rep (2017) 0.75
Dietary intake of fibers: differential effects in men and women on perceived general health and immune functioning. Food Nutr Res (2017) 0.75
Host-microbe interactions in microgravity: assessment and implications. Life (Basel) (2014) 0.75
MicroPattern: a web-based tool for microbe set enrichment analysis and disease similarity calculation based on a list of microbes. Sci Rep (2017) 0.75
Microbiota, Immune Subversion, and Chronic Inflammation. Front Immunol (2017) 0.75
Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice. AMB Express (2017) 0.75
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A (2007) 20.60
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26
The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett (2002) 7.29
Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther (2007) 5.47
Control of intestinal inflammation by regulatory T cells. Immunol Rev (2001) 4.73
Mucin dynamics and enteric pathogens. Nat Rev Microbiol (2011) 4.23
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol (2004) 4.05
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett (2009) 3.48
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35
Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia (2006) 3.21
Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia (2005) 2.21
The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl Environ Microbiol (2007) 2.09
Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes (1990) 2.04
Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr (2009) 1.94
Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (2006) 1.92
Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J (2009) 1.74
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One (2010) 1.70
Influence of fecal sample storage on bacterial community diversity. Open Microbiol J (2009) 1.68
Is childhood-onset type I diabetes a wealth-related disease? An ecological analysis of European incidence rates. Diabetologia (2001) 1.66
Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes (1991) 1.57
Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res (2007) 1.48
Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol (2011) 1.34
Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS (1997) 1.33
The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS One (2011) 1.28
The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J (2009) 1.25
Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis (2010) 1.22
Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes (2006) 1.21
Colonic mucin synthesis is increased by sodium butyrate. Gut (1995) 1.19
Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut (2000) 1.18
Cloning of a mucin-desulfating sulfatase gene from Prevotella strain RS2 and its expression using a Bacteroides recombinant system. J Bacteriol (2000) 1.10
Getting the bugs out of the immune system: do bacterial microbiota "fix" intestinal T cell responses? Cell Host Microbe (2009) 1.05
Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun (1990) 1.01
Quantitative metagenomic analyses based on average genome size normalization. Appl Environ Microbiol (2011) 1.01
Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A Mol Integr Physiol (2000) 0.97
Assessment of heterologous butyrate and butanol pathway activity by measurement of intracellular pathway intermediates in recombinant Escherichia coli. Appl Microbiol Biotechnol (2010) 0.95
Specific amino acids increase mucin synthesis and microbiota in dextran sulfate sodium-treated rats. J Nutr (2006) 0.92
Pyrosequencing enumerates and contrasts soil microbial diversity. ISME J (2007) 13.95
Prevalence of Celiac disease among children in Finland. N Engl J Med (2003) 7.27
Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet (2007) 5.68
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med (2007) 5.48
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum (2002) 4.77
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet (2011) 4.30
Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med (2010) 4.16
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. Lancet (2011) 3.13
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol (2007) 3.08
A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity (2005) 3.07
Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03
Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr (2010) 2.93
Environmental triggers and determinants of type 1 diabetes. Diabetes (2005) 2.93
Functional mapping of quantitative trait loci underlying the character process: a theoretical framework. Genetics (2002) 2.92
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care (2009) 2.91
Complete genome sequence of the N2-fixing broad host range endophyte Klebsiella pneumoniae 342 and virulence predictions verified in mice. PLoS Genet (2008) 2.90
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med (2012) 2.86
Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS One (2011) 2.81
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med (2008) 2.79
The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes (2008) 2.77
Geographic and environmental sources of variation in lake bacterial community composition. Appl Environ Microbiol (2005) 2.68
Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes (2005) 2.63
Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes (2008) 2.52
Web-based phylogenetic assignment tool for analysis of terminal restriction fragment length polymorphism profiles of microbial communities. Appl Environ Microbiol (2003) 2.45
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet (2013) 2.45
The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes (2011) 2.44
Microbial communities and their interactions in soil and rhizosphere ecosystems. Annu Rev Microbiol (2002) 2.41
Diabetes care in the school and day care setting. Diabetes Care (2012) 2.41
A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol (2007) 2.23
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Evaluation of multiple radiographic predictors of cartilage lesions in the hip joints of eight-month-old dogs. Am J Vet Res (2003) 2.09
Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am J Pathol (2004) 2.09
Recombination in circulating enteroviruses. J Virol (2003) 2.08
PANGEA: pipeline for analysis of next generation amplicons. ISME J (2010) 2.05
Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia (2014) 2.04
A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia (2015) 2.02
Formation of a human β-cell population within pancreatic islets is set early in life. J Clin Endocrinol Metab (2012) 2.01
In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes (2004) 2.01
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01
Distantly sampled soils carry few species in common. ISME J (2008) 2.00
B cells enhance early innate immune responses during bacterial sepsis. J Exp Med (2011) 1.99
No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes (2007) 1.99
Hyperglycemia and lower diet quality in pregnant overweight women and increased infant size at birth and at 13 months of age--STEPS study. Early Hum Dev (2013) 1.97
New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism. Nat Genet (2012) 1.90
Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation (2007) 1.89
FTO genotype is associated with body mass index after the age of seven years but not with energy intake or leisure-time physical activity. J Clin Endocrinol Metab (2009) 1.87
Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol (2006) 1.86
Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol (2005) 1.85
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest (2012) 1.84
Synchrony in aquatic microbial community dynamics. ISME J (2007) 1.83
Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr (2003) 1.76
Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J (2009) 1.74